UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Voluntary nullifications of drug license tripled in H1
by Lee Hye-seon
2019-06-26 14:25
Celltrion denies delay in local license application for HIV drug Temixys
by Lee Hye-seon
2019-06-25 10:56
Anti-cancer Sutene could cause central nervous system abnormality in fetus
by Lee Hye-seon
2019-06-24 11:35
LSK Global PS wins international recognition in clinical data management
by Lee Hye-seon
2019-06-13 14:30
Daewoong joins fray to develop rheumatoid arthritis drug
by Lee Hye-seon
2019-06-07 11:29
라인
Regulator faces serious repercussions after Invossa debacle
by Lee Hye-seon
2019-05-29 14:50
Invossa poses almost no safety threat: regulator
by Lee Hye-seon
2019-05-28 16:02
Gore agrees to supply more artificial blood vessels for children
by Lee Hye-seon
2019-05-24 12:53
‘Kolon’s extra data insufficient to explain Invossa mislabeling’
by Lee Hye-seon
2019-05-23 14:51
Regulator inspecting Kolon TissuGene in US this week
by Lee Hye-seon
2019-05-20 14:22
라인
Preventive use of statin lowers cardiovascular mortality by 44% in seniors
by Lee Hye-seon
2019-05-15 11:54
YUHS to introduce ‘hospital medicine department'
by Lee Hye-seon
2019-05-03 13:23
Yonsei Cancer Center to provide newest heavy ion therapy in 2022
by Lee Hye-seon
2019-05-02 15:43
When will regulator visit Kolon TissueGene for inspection?
by Lee Hye-seon
2019-05-02 14:09
Medical device output up 11.8% in 2018
by Lee Hye-seon
2019-04-30 11:25
라인
[Reporter’s Notebook]MFDS incapable of reviewing new drugs?
by Lee Hye-seon
2019-04-29 16:12
Diarrhea drug Smecta banned for children under 2
by Lee Hye-seon
2019-04-24 15:42
OECD guideline OKs Korean-developed eye irritation test
by Lee Hye-seon
2019-04-22 15:33
Kolon desperate to keep Invossa license amid suspicion of data fabrication
by Lee Hye-seon
2019-04-18 11:16
Generic drug approvals doubled amid imminent scrap of consigned bioequivalence tests
by Lee Hye-seon
2019-04-11 16:00
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top